Accelr8's 160 Percent Jump Leads Mixed Month for 'Omics, MDx Stocks | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Accelr8 Technology increased 160 percent in the last week of the month of April, making the firm the top gainer among stocks in the GWDN Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.